Patents Assigned to Chromagen
  • Patent number: 7736868
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: June 15, 2010
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg
  • Patent number: 7736869
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: June 15, 2010
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg
  • Patent number: 7662591
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: February 16, 2010
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg
  • Patent number: 7659094
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: February 9, 2010
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg
  • Patent number: 7655441
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: October 13, 2006
    Date of Patent: February 2, 2010
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg
  • Publication number: 20090011468
    Abstract: The present invention relates to the production of proteins in a cell or host cell. The invention uses a TRAnscription Pause (TRAP) sequence to enhance a protein expression characteristic of a protein expression unit. The TRAP sequence is thought to prevent, at least in part, formation of antisense RNA or to, at least in part, prevent transcription to enter the protein expression unit. In one embodiment, the invention provides a method for expression of at least one protein of interest in a cell comprising providing the cell with at least one protein expression unit that comprises a promoter functionally linked to an open reading frame encoding at least one protein of interest, characterized in that the protein expression unit further comprises at least one TRAP sequence and wherein the TRAP sequence is functionally located downstream of the open reading frame and at least in part prevents formation of antisense RNA.
    Type: Application
    Filed: July 11, 2008
    Publication date: January 8, 2009
    Applicant: Chromagenics B.V.
    Inventors: Arie Pieter Otte, Henricus Johannes Maria Van Blokland
  • Patent number: 7468260
    Abstract: The invention relates to a method of detecting a DNA sequence which at least partially contributes to promote the stable expression of a gene. To this end the DNA fragment to be examined is cloned in a vector between i) a DNA sequence involved in the induction of gene transcription repressing chromatin and ii) a reporter gene. The invention also relates to the detected DNA sequence, and the application of a stable expression-enhancing DNA sequence for the stable expression of a gene.
    Type: Grant
    Filed: October 25, 2004
    Date of Patent: December 23, 2008
    Assignee: ChromaGenics B.V.
    Inventor: Arie Otte
  • Publication number: 20080225289
    Abstract: A fluorescence spectrophotometer system may be implemented in scanning fluorescence polarization detection applications. A wavelength and area scanning fluorescence spectrophotometer system may include a light source, an excitation double monochromator, an excitation/emission light transfer module, an emission double monochromator, a high speed timer-counter circuit board, a precision positioning apparatus for positioning a sample relative to the focal plane of the excitation light, and polarizing filters at the excitation side and the emission side. The system may be operative to analyze more than one fluorescent compound in the sample; additionally or alternatively, the system enables analysis of samples from selected ones of a plurality of samples.
    Type: Application
    Filed: March 31, 2008
    Publication date: September 18, 2008
    Applicant: CHROMAGEN, INC.
    Inventors: Gene Gould, Michael J. Conrad
  • Publication number: 20080206813
    Abstract: Described are means and methods for regulating gene expression and production of proteinaceous molecules. Described are methods for producing a proteinaceous molecule in a cell comprising selecting a cell for its suitability for producing the proteinaceous molecule, providing a nucleic acid encoding the proteinaceous molecule with a nucleic acid comprising a STAR (STabilizing Anti-Repression) sequence, expressing the resulting nucleic acid in the cell and collecting the proteinaceous molecule. Providing at least one STAR sequence to a nucleic acid encoding a proteinaceous molecule enhances production (yield) of the proteinaceous molecule by the host cell, increases the proportion of host cells with acceptable expression levels, and/or increases the stability of a gene expression level.
    Type: Application
    Filed: October 26, 2007
    Publication date: August 28, 2008
    Applicant: ChromaGenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg, David P. E. Satijn
  • Patent number: 7413896
    Abstract: The present invention relates to the production of proteins in a cell or host cell. The invention uses a TRAnscription Pause (TRAP) sequence to enhance a protein expression characteristic of a protein expression unit. The TRAP sequence is thought to prevent, at least in part, formation of antisense RNA or to, at least in part, prevent transcription to enter the protein expression unit. In one embodiment, the invention provides a method for expression of at least one protein of interest in a cell comprising providing the cell with at least one protein expression unit that comprises a promoter functionally linked to an open reading frame encoding at least one protein of interest, characterized in that the protein expression unit further comprises at least one TRAP sequence and wherein the TRAP sequence is functionally located downstream of the open reading frame and at least in part prevents formation of antisense RNA.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: August 19, 2008
    Assignee: Chromagenics B.V.
    Inventors: Arie Pieter Otte, Henricus Johannes Maria van Blokland
  • Patent number: 7411673
    Abstract: A fluorescence spectrophotometer having an excitation double monochromator, a coaxial excitation/emission light transfer module, and an emission double monochromator. Each monochromator includes a pair of holographic concave gratings mounted to precisely select a desired band of wavelengths from incoming broadband light without using other optical elements, such as mirrors. Selected excitation light is directed into a sample well by a light transfer module that includes a coaxial excitation mirror positioned to direct excitation light directly to the bottom of a well of a multi-well plate. Fluorescence emission light that exits the well opening is collected by a relatively large coaxial emission mirror. The collected emission light is wavelength selected by the emission double monochromator. Selected emission light is detected by a photodetector module.
    Type: Grant
    Filed: September 8, 2003
    Date of Patent: August 12, 2008
    Assignee: Chromagen, Inc.
    Inventors: Gene Gould, Michael J. Conrad
  • Publication number: 20080131930
    Abstract: The invention relates to means and methods for regulating gene expression and production of proteinaceous molecules. The invention provides a method for producing a proteinaceous molecule in a cell comprising selecting a cell for its suitability for producing the proteinaceous molecule, providing a nucleic acid encoding the proteinaceous molecule with a nucleic acid comprising a STAR (STabilizing Anti-Repression) sequence, expressing the resulting nucleic acid in the cell and collecting the proteinaceous molecule. Providing at least one STAR sequence to a nucleic acid encoding a proteinaceous molecule will enhance production (yield) of the proteinaceous molecule by a host cell, increase the proportion of host cells with acceptable expression levels, and/or increase stability of a gene expression level.
    Type: Application
    Filed: July 31, 2007
    Publication date: June 5, 2008
    Applicant: ChromaGenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg, David P.E. Satijn
  • Patent number: 7364878
    Abstract: The invention relates to the field of biochemistry, molecular biology, pharmacology and diagnosis. More specifically the present invention relates to the production of proteins in a host cell. Even more specifically, the invention relates to a method for improving expression of two or more proteins in a (host) cell. The method is suited for production of, for example, recombinant antibodies that can be used in a pharmaceutical preparation or as a diagnostic tool. In one embodiment, the invention provides a method for obtaining a cell which expresses two or more proteins comprising providing the cell with two or more protein expression units encoding two or more proteins, characterized in that at least two of the protein expression units comprise at least one STAR sequence.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: April 29, 2008
    Assignee: Chromagenics B.V.
    Inventors: Arie Pieter Otte, Arthur Leo Kruckeberg, Richard George Antonius Bernardus Sewalt
  • Publication number: 20080085537
    Abstract: The invention provides a DNA molecule comprising a multicistronic transcription unit coding for i) a polypeptide of interest, and for ii) a selectable marker polypeptide functional in a eukaryotic host cell, wherein the polypeptide of interest has a translation initiation sequence separate from that of the selectable marker polypeptide, and wherein the coding sequence for the polypeptide of interest is upstream from the coding sequence for the selectable marker polypeptide in the multicistronic transcription unit, and wherein an internal ribosome entry site is present downstream from the coding sequence for the polypeptide of interest and upstream from the coding sequence for the selectable marker polypeptide, and wherein the nucleic acid sequence coding for the selectable marker polypeptide in the coding strand comprises a GTG or a TTG start codon. Also provided are methods for obtaining host cells expressing a polypeptide of interest, such host cells comprising DNA molecules of the invention.
    Type: Application
    Filed: September 6, 2007
    Publication date: April 10, 2008
    Applicant: ChromaGenics B.V.
    Inventors: Arie Otte, Theodorus Kwaks, Henricus van Blokland, Richard Sewalt
  • Patent number: 7352459
    Abstract: A fluorescence spectrophotometer system may be implemented in scanning fluorescence polarization detection applications. A wavelength and area scanning fluorescence spectrophotometer system may include a light source, an excitation double monochromator, an excitation/emission light transfer module, an emission double monochromator, a high speed timer-counter circuit board, a precision positioning apparatus for positioning a sample relative to the focal plane of the excitation light, and polarizing filters at the excitation side and the emission side. The system may be operative to analyze more than one fluorescent compound in the sample; additionally or alternatively, the system enables analysis of samples from selected ones of a plurality of samples.
    Type: Grant
    Filed: December 31, 2001
    Date of Patent: April 1, 2008
    Assignee: Chromagen, Inc.
    Inventors: Gene Gould, Michael J. Conrad
  • Patent number: 7267965
    Abstract: The invention relates to means and methods for regulating gene expression and production of proteinaceous molecules. The invention provides a method for producing a proteinaceous molecule in a cell comprising selecting a cell for its suitability for producing the proteinaceous molecule, providing a nucleic acid encoding the proteinaceous molecule with a nucleic acid comprising a STAR (STabilizing Anti-Repression) sequence, expressing the resulting nucleic acid in the cell and collecting the proteinaceous molecule. Providing at least one STAR sequence to a nucleic acid encoding a proteinaceous molecule will enhance production (yield) of the proteinaceous molecule by a host cell, increase the proportion of host cells with acceptable expression levels, and/or increase stability of a gene expression level.
    Type: Grant
    Filed: December 14, 2004
    Date of Patent: September 11, 2007
    Assignee: Chromagenics B.V.
    Inventors: Arie P. Otte, Arthur L. Kruckeberg, David P. E. Satijn
  • Publication number: 20070128717
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Application
    Filed: January 15, 2007
    Publication date: June 7, 2007
    Applicant: Chromagenics B.V.
    Inventors: Arie Otte, Arthur Kruckeberg
  • Patent number: 7192741
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: March 20, 2007
    Assignee: Chromagenics B.V.
    Inventors: Arie Peter Otte, Arthur Leo Kruckeberg
  • Publication number: 20070037256
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Application
    Filed: October 13, 2006
    Publication date: February 15, 2007
    Applicant: ChromaGenics B.V.
    Inventors: Arie Otte, Arthur Kruckeberg
  • Publication number: 20070031936
    Abstract: The invention is concerned with the systematic elucidation and identification of regulatory sequences. The invention provides among others screenings and detection methods with which regulatory sequences can be identified. The invention further provides regulatory sequences and use thereof in various fields such as, but not limited to, protein production, diagnostics, transgenic plants and animals, and the therapeutic field.
    Type: Application
    Filed: October 13, 2006
    Publication date: February 8, 2007
    Applicant: ChromaGenics B.V.
    Inventors: Arie Otte, Arthur Kruckeberg